FIELD: chemistry.
SUBSTANCE: present invention relates to tricyclic compounds of formula 1 and pharmaceutically acceptable salts possessing antibacterial properties, as well as to a method for production thereof, pharmaceutical preparations based thereon and method of treating using same.
EFFECT: in general formula 1 R1 and R2 denote hydrogen or methyl.
9 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED 3,4,12,12A-TETRAHYDRO-1H-[1,4]OXAZINO[3,4-C]PYRIDO[2,1-F][1,2,4]TRIAZINE-6,8-DIONE, PHARMACEUTICAL COMPOSITION, METHODS FOR PRODUCTION AND USE THEREOF | 2019 |
|
RU2720305C1 |
| [4-(1-AMINOETHYL)CYCLOHEXYL]METHYLAMINE AND [6-(1-AMINOETHYL)TETRAHYDROPYRAN-3-YL]METHYLAMINE DERIVATIVES | 2009 |
|
RU2515906C2 |
| TRICYCLIC TRIAZOLIC COMPOUNDS | 2014 |
|
RU2666728C2 |
| 5-AMINOCYCLYLMETHYLOXAZOLIDIN-2-ONE DERIVATIVES | 2008 |
|
RU2492169C2 |
| OXAZOLIDINE ANTIBIOTICS | 2009 |
|
RU2516701C2 |
| NOVEL COMPOUNDS WITH ANTIBACTERIAL ACTION | 2004 |
|
RU2397982C2 |
| NOVEL CONDENSED PYRIDINE DERIVATIVES USED AS C-MET TYROSINE KINASE INHIBITORS | 2013 |
|
RU2619130C2 |
| 5-AMINO-2-(1-HYDROXYETHYL)TETRAHYDROPYRAN DERIVATIVES | 2009 |
|
RU2525541C2 |
| METALLO-β-LACTAMASE INHIBITORS | 2006 |
|
RU2462450C2 |
| TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS | 2009 |
|
RU2530884C2 |
